Patents by Inventor Jesper Færgeman Lau

Jesper Færgeman Lau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Semi-recombinant preparation of GLP-1 analogues
    Patent number: 9732137
    Abstract: A semi-recombinant method for the production of GLP-1 analogues and derivatives with non-proteogenic amino acids in the N-terminal part combining the use of recombinant expression techniques and chemical peptide synthesis.
    Type: Grant
    Filed: December 22, 2008
    Date of Patent: August 15, 2017
    Assignee: Novo Nordisk A/S
    Inventors: Jesper Færgeman Lau, Asser Sloth Andersen, Paw Bloch, Jesper Lau, Patrick William Garibay, Thomas Kruse, Inga Sig Nielsen Nørby, Claus Ulrich Jessen, Caspar Christensen, Jens Christian Norrild
  • SEMI-RECOMBINANT PREPARATION OF GLP-1 ANALOGUES
    Publication number: 20100317057
    Abstract: A semi-recombinant method for the production of GLP-1 analogues and derivatives with non-proteogenic amino acids in the N-terminal part combining the use of recombinant expression techniques and chemical peptide synthesis.
    Type: Application
    Filed: December 22, 2007
    Publication date: December 16, 2010
    Applicant: NOVO NORDISK A/S
    Inventors: Jesper Faergeman Lau, Asser Sloth Andersen, Paw Bloch, Jesper Lau, Patrick William Garibay, Thomas Kruse, Inga Sig Nielsen Nørby, Claus Ulrich Jessen, Caspar Christensen, Jens Christian Norrild